Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels (VGCCs) are essential pore-forming transmembrane proteins that mediate the entry of calcium ions into cells upon membrane depolarization, triggering various intracellular processes. These channels are classified into high-voltage activated (L-, P/Q-, N-, and R-type) and low-voltage activated (T-type) groups, each with distinct physiological roles in muscle contraction, hormone secretion, and neurotransmission [1][2]. Calcium-binding proteins (CBPs), such as calmodulin, troponin C, and S100 proteins, function as intracellular calcium sensors or buffers that translate calcium fluctuations into biological responses [3]. Together, these proteins maintain calcium homeostasis and regulate signaling pathways critical for cellular function. Mutations or dysregulation in these proteins are implicated in a wide range of channelopathies and diseases, including hypertension, cardiac arrhythmias, epilepsy, and chronic pain [1][4]. Therapeutic agents targeting VGCCs, such as dihydropyridines and gabapentinoids, are widely used in clinical practice to manage cardiovascular and neurological conditions [4]. This target entry is considered incorrect for structured data purposes as it aggregates multiple distinct protein families and channel types into a single heterogeneous category [5]. Sources: [1] StatPearls, Physiology, Voltage-Gated Calcium Channels (2023). [2] UniProt Consortium, Voltage-dependent L-type calcium channel subunit alpha-1C (P16230). [3] PubMed, Calcium-binding proteins in health and disease, PMID: 30243712. [4] NIH, Calcium Channel Blockers (2023). [5] IUPHAR/BPS Guide to Pharmacology, Voltage-gated calcium channels.
Inhibition of calcium ion influx through voltage-gated channels; modulation of calcium-dependent signaling pathways; stabilization of inactive channel conformations.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel and calcium-binding protein (VGCC/CBP).